Pathophysiology of an hypoxic-ischemic insult during the perinatal period

Neurological Research

Volumn 27, Issue 3, 2005, Pages 246-260

  Calvert, John W ^b   Zhang, John H ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Apoptosis; Hyperbaric oxygen; Hypothermia; Hypoxia; Inflammation; Ischemia; Perinatal; Treatment outcome; White matter

Indexed keywords

CALCIUM; FREE RADICAL; GLUTAMATE RECEPTOR; NEUROTRANSMITTER; OXYGEN; OXYGEN RADICAL;

APOPTOSIS; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; BRAIN EDEMA; BRAIN ENERGY FAILURE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN METABOLISM; CALCIUM CELL LEVEL; CEREBRAL PALSY; EMOTIONAL STRESS; HUMAN; HYPERBARIC OXYGEN; HYPOTHERMIA; INCIDENCE; INDUCED HYPOTHERMIA; INFLAMMATION; LIFESPAN; LIPID PEROXIDATION; MEMBRANE DEPOLARIZATION; MENTAL DISEASE; METABOLIC DISORDER; MOTOR DYSFUNCTION; NERVE CELL NECROSIS; NEUROTRANSMITTER RELEASE; OXYGEN THERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PERINATAL MORBIDITY; PERINATAL MORTALITY; PERINATAL PERIOD; PHYSICAL STRESS; REVIEW; SEIZURE; TREATMENT OUTCOME; WHITE MATTER; WHITE MATTER INJURY;

ANIMALS; APOPTOSIS; BRAIN INJURIES; CALCIUM; FEMALE; FREE RADICALS; HUMANS; HYPOTHERMIA; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INFLAMMATION; MALE; MODELS, NEUROLOGICAL; OXYGEN; PREGNANCY; RECEPTORS, GLUTAMATE;

EID: 17144428095     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X25216     Document Type: Review

References (217)

1. Lievre V, Becuwe P, Blanchi A, et al. Intracellular generation of free radicals and modifications of detoxifying enzymes in cultured neurons from the developing rat forebrain in response to transient hypoxia. Neuroscience 2001; 105: 287-297
2. Vannucci RC, Vannucci SJ. A model of perinatal hypoxic-ischemic brain damage. Ann NY Acad Sci 1997; 835: 234-249
3. Jiang X, Mu D, Sheldon RA, et al. Neonatal hypoxia-ischemia differentially upregulates MAGUKs and associated proteins in PSD-93-deficient mouse brain. Stroke 2003; 34: 2958-2963
4. Greenwood K, Cox P, Mehmet H, et al. Magnesium sulfate treatment after transient hypoxia-ischemia in the newborn piglet does not protect against cerebral damage. Pediatr Res 2000; 48: 346-350
5. Vannucci RC, Connor JR, Mauger DT, et al. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res 1999; 55: 158-163
6. Groenendaal F, de Graaf RA, van Vliet G, et al. Effects of hypoxia-ischemia and inhibition of nitric oxide synthase on cerebral energy metabolism in newborn piglets. Pediatr Res 1999; 45: 827-833
7. Sunshine P. Hypoxic-ischemic encephalopathy: Pathophysiology and implications for therapy. Przegl Lek 2002; 59 (Suppl 1): 6-9
8. Puka-Sundvall M, Sandberg M, Hagberg H. Brain injury after hypoxia-ischemia in newborn rats: Relationship to extracellular levels of excitatory amino acids and cysteine. Brain Res 1997; 750: 325-328
9. Bagenholm R, Nilsson UA, Kjellmer I. Formation of free radicals in hypoxic ischemic brain damage in the neonatal rat, assessed by an endogenous spin trap and lipid peroxidation. Brain Res 1997; 773: 132-138
10. Calvert JW, Yin W, Patel M, et al. Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model. Brain Res 2002; 951: 1-8
11. Du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002; 15: 151-157
12. Berger R, Garnier Y. Perinatal brain injury. J Perinat Med 2000; 28: 261-285
13. Takeoka M, Soman TB, Yoshii A, et al. Diffusion-weighted images in neonatal cerebral hypoxic-ischemic injury. Pediatr Neurol 2002; 26: 274-281
14. Evrard P. Pathophysiology of perinatal brain damage. Dev Neurosci 2001; 23: 171-174
15. Roohey T, Raju TN, Moustogiannis AN. Animal models for the study of perinatal hypoxic-ischemic encephalopathy: A critical analysis. Early Hum Dev 1997; 47: 115-146
16. Saliba E, Barantin L, Akoka S, et al. Circulation and cerebral metabolism in neonatal hypoxia-ischemia. J Gynecol Obstet Biol Reprod (Paris) 1997; 26: 465-469
17. Vannucci SJ. Developmental expression of GLUT1 and GLUT3 glucose transporters in rat brain. J Neurochem 1994; 62: 240-246
18. Vannucci SJ, Reinhart R, Maher F, et al. Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Brain Res Dev Brain Res 1998; 107: 255-264
19. Ioroi T, Peeters-Scholte C, Post I, et al. Changes in cerebral haemodynamics, regional oxygen saturation and amplitude-integrated continuous EEC during hypoxia-ischaemia and reperfusion in newborn piglets. Exp Brain Res 2002; 144: 172-177
20. Thorngren-Jerneck K, Ley D, Hellstrom-Westas L, et al. Reduced postnatal cerebral glucose metabolism measured by PET after asphyxia in near term fetal lambs. J Neurosci Res 2001; 66: 844-850
21. Seidl R, Stockler-Ipsiroglu S, Rolinski B, et al. Energy metabolism in graded perinatal asphyxia of the rat. Life Sci 2000; 67: 421-435
22. Williams GD, Palmer C, Heitjan DF, et al. Allopurinol preserves cerebral energy metabolism during perinatal hypoxia-ischemia: A 31P NMR study in unanesthetized immature rats. Neurosci Lett 1992; 144: 103-106
23. Williams GD, Palmer C, Roberts RL, et al. 31 PNMR spectroscopy of perinatal hypoxic-ischemic brain damage: A model to evaluate neuroprotective drugs in immature rats. NMR Biomed 1992; 5: 145-153
24. Palmer C, Brucklacher RM, Christensen MA, et al. Carbohydrate and energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. J Cereb Blood Flow Metab 1990; 10: 227-235
25. Yager JY, Brucklacher RM, Vannucci RC. Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats. Am J Physiol 1992; 262: H672-H677
26. Vannucci RC, Yager JY, Vannucci SJ. Cerebral glucose and energy utilization during the evolution of hypoxic-ischemic brain damage in the immature rat. J Cereb Blood Flow Metab 1994; 14: 279-288
27. Thorngren-Jerneck K, Ohlsson T, Sandell A, et al. Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 2001; 49: 495-501
28. Hanrahan JD, Cox IJ, Azzopardi D et al. Relation between proton magnetic resonance spectroscopy within 18 hours of birth asphyxia and neurodevelopment at 1 year of age. Dev Med Child Neurol 1999; 41: 76-82
29. Roth SC, Edwards AD, Cady EB, et al. Relation between cerebral oxidative metabolism following birth asphyxia, and neurodevelopmental outcome and brain growth at one year. Dev Med Child Neurol 1992; 34: 285-295
30. Cai Z, Xiao F, Fratkin JD, et al. Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist. Neuroreport 1999; 10: 3927-3931
31. Mahura IS. Cerebral ischemia-hypoxia and biophysical mechanisms of neurodegeneration and neuroprotection effects. Fiziol Zh 2003; 49: 7-12
32. Crow J, Barks JD. Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: Current concepts. Clin Perinatol 2002; 29: 585-602
33. Nunez JL, Alt JJ, McCarthy MM. A new model for prenatal brain damage. I. GABAA receptor activation induces cell death in developing rat hippocampus. Exp Neurol 2003; 181: 258-269
34. Rodriguez MJ, Ursu C, Bernal F, et al. Perinatal human hypoxia-ischemia vulnerability correlates with brain calcification. Neurobiol Dis 2001; 8: 59-68
35. Feng Y, Piletz JE, LeBlanc MH. Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 2002; 52: 606-611
36. Mobley LW III, Agrawal SK. Role of calcineurin in calcium-mediated hypoxic injury to white matter. Spine J 2003; 3: 11-18
37. Vannucci RC, Brucklacher RM, Vannucci SJ. Intracellular calcium accumulation during the evolution of hypoxic-ischemic brain damage in the immature rat. Brain Res Dev Brain Res 2001; 126: 117-120
38. Zanelli SA, Numagami Y, McGowan JE, et al. NMDA receptor-mediated calcium influx in cerebral cortical synaptosomes of the hypoxic guinea pig fetus. Neurochem Res 1999; 24: 437-446
39. Fritz KI, Zanelli S, Mishra OP, et al. Effect of graded hypoxia on the high-affinity CPP binding site of the NMDA receptor in the cerebral cortex of newborn piglets. Brain Res 2001; 891: 266-273
40. Brandoli C, Sanna A, De Bernardi MA, et al. Brain-derived neurotrophic factor and basic fibroblast growth factor down-regulate NMDA receptor function in cerebellar granule cells. J Neurosci 1998; 18: 7953-7961
41. Alkan T, Kahveci N, Buyukuysal L, et al. Neuroprotective effects of MK 801 and hypothermia used alone and in combination in hypoxic-ischemic brain injury in neonatal rats. Arch Physiol Biochem 2001; 109: 135-144
42. Hagberg H, Gilland E, Diemer NH, et al. Hypoxia-ischemia in the neonatal rat brain: Histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol Neonate 1994; 66: 205-213
43. Albensi BC, Schweizer MP, Rarick TM, et al. Unilateral hypoxic-ischemic injury in the neonatal rat brain evaluated by in vivo MRI. Correlation with histopathology and neuroprotection by MK-801. Invest Radiol 1999; 34: 249-261
44. Gunn AJ, Williams CE, Bennet L, et al. Perinatal cerebral asphyxia: Pharmacological intervention. Fetal Ther 1988; 3: 98-107
45. Ochiai-Kanai R, Hasegawa K, Takeuchi Y, et al. Immunohistochemical nitrotyrosine distribution in neonatal rat cerebrocortical slices during and after hypoxia. Brain Res 1999; 847: 59-70
46. Puka-Sundvall M, Hallin U, Zhu C, et al. NMDA blockade attenuates caspase-3 activation and DNA fragmentation after neonatal hypoxia-ischemia. Neuroreport 2000; 11: 2833-2836
47. Engidawork E, Loidl F, Chen Y, et al. Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia. Exp Brain Res 2001; 138: 375-383
48. Spandou E, Karkavelas G, Soubasi V, et al. Effect of ketamine on hypoxic-ischemic brain damage in newborn rats. Brain Res 1999; 819: 1-7
49. Follett PL, Rosenberg PA, Volpe JJ, et al. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000; 20: 9235-9241
50. Almli CR, Levy TJ, Han BH, et al. BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia. Exp Neurol 2000; 166: 99-114
51. Cheng Y, Gidday JM, Yan Q, et al. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol 1997; 41: 521-529
52. Galvin KA, Oorschot DE. Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ ischemia: A stereological study. Neuroscience 2003; 118: 1023-1032
53. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000; 20: 5775-5781
54. Han BH, D'Costa A, Back SA, et al. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis 2000; 7: 38-53
55. Hong X, Zheng L, Chen X. Changes of dynorphinA1-13 on the treatment of hypoxic-ischemic brain injury by the brain-derived neurotrophic factor in neonatal rats. Zhonghua Yi Xue Za Zhi 2002; 82: 1637-1640
56. Ikeda T, Xia XY, Xia YX, et al. Glial cell line-derived neurotrophic factor protects against ischemia/hypoxia-induced brain injury in neonatal rat. Acta Neuropathol (Berl) 2000; 100: 161-167
57. Saito K, Packianathan S, Longo LD. Free radical-induced elevation of ornithine decarboxylase activity in developing rat brain slices. Brain Res 1997; 763: 232-238
58. Ogihara T, Hirano K, Ogihara H et al. Non-protein-bound transition metals and hydroxyl radical generation in cerebrospinal fluid of newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 2003; 53: 594-599
59. Ditelberg JS, Sheldon RA, Epstein CJ, et al. Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice. Pediatr Res 1996; 39: 204-208
60. Bagenholm R, Nilsson UA, Gotborg CW, et al. Free radicals are formed in the brain of fetal sheep during reperfusion after cerebral ischemia. Pediatr Res 1998; 43: 271-275
61. Fullerton HJ, Ditelberg JS, Chen SF, et al. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 1998; 44: 357-364
62. Groenendaal F, Mishra OP, McGowan JE, et al. Function of cell membranes in cerebral cortical tissue of newborn piglets after hypoxia and inhibition of nitric oxide synthase. Pediatr Res 1997; 42: 174-179
63. Yonetani M. The role of nitric oxide in hypoxic-ischemic injury. No To Hattatsu 1996; 28: 125-127
64. Peeters C, van Bel F. Pharmacotherapeutical reduction of post-hypoxic-ischemic brain injury in the newborn. Biol Neonate 2001; 79: 274-280
65. Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J Nutr 2003; 133: 3275S-3284S
66. Marro PJ, McGowan JE, Razdan B, et al. Effect of allopurinol on uric acid levels and brain cell membrane Na+,K(+)-ATPase activity during hypoxia in newborn piglets. Brain Res 1994; 650: 9-15
67. Palmer C, Towfighi J, Roberts RL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993; 33: 405-411
68. Murrell GA, Rapeport WG. Clinical pharmacokinetics of allopurinol. Clin Pharmacokinet 1986; 11: 343-353
69. Feng Y, Shi W, Huang M, et al. Oxypurinol administration fails to prevent hypoxic-ischemic brain injury in neonatal rats. Brain Res Bull 2003; 59: 453-457
70. Malinski T, Bailey F, Zhang ZG, et al. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 1993; 13: 355-358
71. Kader A, Frazzini VI, Solomon RA, et al. Nitric oxide production during focal cerebral ischemia in rats. Stroke 1993; 24: 1709-1716
72. Weller R. Nitric oxide: A key mediator in cutaneous physiology. Clin Exp Dermatol 2003; 28: 511-514
73. Ferriero DM, Holtzman DM, Black SM, et al. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 1996; 3: 64-71
74. Loidl CF, De Vente J, van Ittersum MM, et al. Hypothermia during or after severe perinatal asphyxia prevents increase in cyclic GMP-related nitric oxide levels in the newborn rat striatum. Brain Res 1998; 791: 303-307
75. Loidl CF, Capani F, Lopez-Costa JJ, et al. Short-term changes in NADPH-diaphorase reactivity in rat brain following perinatal asphyxia. Neuroprotective effects of cold treatment. Mol Chem Neuropathol 1997; 31: 301-316
76. Higuchi Y, Hattori H, Kume T, et al. Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur J Pharmacol 1998; 342: 47-49
77. Ishida A, Trescher WH, Lange MS, et al. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 2001; 23: 349-354
78. Muramatsu K, Sheldon RA, Black SM, et al. Nitric oxide synthase activity and inhibition after neonatal hypoxia ischemia in the mouse brain. Brain Res Dev Brain Res 2000; 123: 119-127
79. Tsuji M, Higuchi Y, Shiraishi K, et al. Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr Res 2000; 47: 79-83
80. van den Tweel ER, Peeters-Scholte CM, van Bel F, et al. Inhibition of nNOS and iNOS following hypoxia-ischaemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat brain. Dev Neurosci 2002; 24: 389-395
81. Peeters-Scholte C, Koster J, van den TE, et al. Effects of selective nitric oxide synthase inhibition on IGF-1, caspases and cytokines in a newborn piglet model of perinatal hypoxia-ischaemia. Dev Neurosci 2002; 24: 396-404
82. Peeters-Scholte C, van den TE, Ioroi T, et al. Pharmacological interventions in the newborn piglet in the first 24 h after hypoxia-ischemia. A hemodynamic and electrophysiological perspective. Exp Brain Res 2002; 147: 200-208
83. Peeters-Scholte C, Koster J, Veldhuis W, et al. Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia. Stroke 2002; 33: 2304-2310
84. Dorrepaal CA, van Bel F, Moison RM, et al. Oxidative stress during post-hypoxic-ischemic reperfusion in the newborn lamb: The effect of nitric oxide synthesis inhibition. Pediatr Res 1997; 41: 321-326
85. Dorrepaal CA, Steendijk P, Baan J, et al. Inhibition of nitric oxide synthesis following severe hypoxia-ischemia restores autoregulation of cerebral blood flow in newborn lambs. Early Hum Dev 2001; 60: 159-170
86. Mishra OP, Ashraf QM, Delivoria-Papadopoulos M. Phosphorylation of cAMP response element binding (CREB) protein during hypoxia in cerebral cortex of newborn piglets and the effect of nitric oxide synthase inhibition. Neuroscience 2002; 115: 985-991
87. Spanggord H, Sheldon RA, Ferriero DM. Cysteamine eliminates nitric oxide synthase activity but is not protective to the hypoxic-ischemic neonatal rat brain. Neurosci Lett 1996; 213: 41-44
88. Sarco DP, Becker J, Palmer C, et al. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain. Neurosci Lett 2000; 282: 113-116
89. Shimizu K, Rajapakse N, Horiguchi T, et al. Neuroprotection against hypoxia-ischemia in neonatal rat brain by novel superoxide dismutase mimetics. Neurosci Lett 2003; 346: 41-44
90. Ikeda T, Xia YX, Kaneko M, et al. Effect of the free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on hypoxia-ischemia-induced brain injury in neonatal rats. Neurosci Lett 2002; 329: 33-36
91. The Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003; 15: 222-229
92. Bona E, Andersson AL, Blomgren K, et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999; 45: 500-509
93. Anthony DC, Bolton SJ, Fearn S, et al. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997; 120 (Pt 3): 435-444
94. Saliba E, Henrot A. Inflammatory mediators and neonatal brain damage. Biol Neonate 2001; 79: 224-227
95. Kevil CG. Endothelial cell activation in inflammation: Lessons from mutant mouse models. Pathophysiology 2003; 9: 63-74
96. Uhm CS, Kim KB, Lim JH, et al. Effective treatment with fucoidin for perinatal hypoxic-ischemic encephalopathy in rats. Neurosci Lett 2003; 353: 21-24
97. Keller C, Webb A, Davis J. Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: A brief report and literature review. Ann Rheum Dis 2003; 62: 1128-1132
98. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25: 1481-1488
99. Silverstein FS, Barks JD, Hagan P, et al. Cytokines and perinatal brain injury. Neurochem Int 1997; 30: 375-383
100. Shalak LF, Laptook AR, Jafri HS, et al. Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics 2002; 110: 673-680
101. Foster-Barber A, Dickens B, Ferriero DM. Human perinatal asphyxia: Correlation of neonatal cytokines with MRI and outcome. Dev Neurosci 2001; 23: 213-218
102. Chiesa C, Pellegrini G, Panero A, et al. Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest 2003; 33: 352-358
103. Szaflarski J, Burtrum D, Silverstein FS. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995; 26: 1093-1100
104. Hagberg H, Gilland E, Bona E, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996; 40: 603-609
105. Martin D, Chinookoswong N, Miller G. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 1994; 130: 362-367
106. Rice JE III, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9: 131-141
107. Hedtjarn M, Leverin AL, Eriksson K, et al. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002; 22: 5910-5919
108. Eun BL, Liu XH, Barks JD. Pentoxifylline attenuates hypoxic-ischemic brain injury in immature rats. Pediatr Res 2000; 47: 73-78
109. Viswanath M, Palmer C, Roberts RL. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: Lack of long-term protection. Pediatr Res 2000; 48: 109-113
110. Balduini W, Mazzoni E, Carloni S, et al. Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1 beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke 2003; 34: 2007-2012
111. Froen JF, Munkeby BH, Stray-Pedersen B, et al. Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation on perinatal cerebral hypoxia-ischemia. Brain Res 2002; 942: 87-94
112. Mesples B, Plaisant F, Gressens P. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 2003; 141: 25-32
113. Ivacko J, Szaflarski J, Malinak C, et al. Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain. J Cereb Blood Flow Metab 1997; 17: 759-770
114. Park SY, Lee H, Hur J, et al. Hypoxia induces nitric oxide production in mouse microglia via p38 mitogen-activated protein kinase pathway. Brain Res Mol Brain Res 2002; 107: 9-16
115. Cowell RM, Xu H, Calasso JM, et al. Hypoxic-ischemic injury induces macrophage inflammatory protein-1 alpha expression in immature rat brain. Stroke 2002; 33: 795-801
116. McRae A, Gilland E, Bona E, et al. Microglia activation after neonatal hypoxic-ischemia. Brain Res Dev Brain Res 1995; 84: 245-252
117. Cowell RM, Plane JM, Silverstein FS. Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. 1 Neurosci 2003; 23: 9459-9468
118. Banasiak KJ, Xia Y, Haddad GG. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 2000; 62: 215-249
119. Edwards AD, Mehmet H. Apoptosis in perinatal hypoxic-ischaemic cerebral damage. Neuropathol Appl Neurobiol 1996; 22: 494-498
120. Jiang L, Ding Y, Tang Y. Relationship between c-fos gene expression and delayed neuronal death in rat neonatal hippocampus following hypoxic-ischemic insult. Chin Med J (Engl) 2001; 114: 520-523
121. Mu D, Liang W, Zhang G, et al. The relationship between the c-jun mRNA expression and apoptosis of neurons in rat brain following perinatal ischemic-hypoxia. Chin Med J (Engl) 1999; 112: 40-43
122. Puka-Sundvall M, Gajkowska B, Cholewinski M, et al. Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats Brain Res Dev Brain Res 2000; 125: 31-41
123. Hill IE, MacManus JP, Rasquinha I, et al. DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat. Brain Res 1995; 676: 398-403
124. Clawson TF, Vannucci SJ, Wang GM, et al. Hypoxia-ischemia-induced apoptotic cell death correlates with IGF-1 mRNA decrease in neonatal rat brain, Biol Signals Recept 1999; 8: 281-293
125. Itoh M. (Perinatal ischemic brain damages and apoptosis). No To Hattatsu 1999; 31: 140-145
126. Pulera MR, Adams LM, Liu H, et al. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke 1998; 29: 2622-2630
127. Edwards AD, Yue X, Cox P, et al. Apoptosis in the brains of infants suffering intrauterine cerebral injury. Pediatr Res 1997; 42: 684-689
128. Martin LJ, Al Abdulla NA, Brambrink AM, et al. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998; 46: 281-309
129. Mehmet H, Yue X, Squier MV, et al. Increased apoptosis in the cingulate sulcus of newborn piglets following transient hypoxia-ischaemia is related to the degree of high energy phosphate depletion during the insult. Neurosci Lett 1994; 181: 121-125
130. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101: 1992-1999
131. Blomgren K, Zhu C, Wang X, et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia- ischemia: A mechanism of "pathological apoptosis"? J Biol Chem 2001; 276: 10191-10198
132. Calvert JW, Zhou C, Nanda A, et al. Effect of hyperbaric oxygen on apoptosis in neonatal hypoxia-ischemia rat model. J Appl Physiol 2003; 95: 2072-2080
133. Rossiter JP, Anderson LL, Yang F, et al. Caspase-3 activation and caspase-like proteolytic activity in human perinatal hypoxic-ischemic brain injury. Acta Neuropathol (Berl) 2002; 103: 66-73
134. Zhu C, Qiu L, Wang X, et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem 2003; 86: 306-317
135. Adachi M, Sohma O, Tsuneishi S, et al. Combination effect of systemic hypothermia and caspase inhibitor administration against hypoxic-ischemic brain damage in neonatal rats. Pediatr Res 2001; 50: 590-595
136. Joly LM, Mucignat V, Mariani J, et al. Caspase inhibition after neonatal ischemia in the rat brain. J Cereb Blood Flow Metab 2004; 24: 124-131
137. Arvin KL, Han BH, Du Y, et al. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 2002; 52: 54-61
138. Feng Y, LeBlanc MH. N-Tosyl-L-phenylalanyl-chloromethyl ketone eliminates the increase in caspase-3 and bcl-2 caused by brain injury in the newborn rat. Pharmacology 2002; 66: 115-119
139. Feng Y, LeBlanc MH. Treatment of hypoxic-ischemic brain injury in newborn rats with TPCK 3 h after hypoxia decreases caspase-9 activation and improves neuropathologic outcome. Dev Neurosci 2003; 25: 34-40
140. LeBlanc MH, Feng Y, Fratkin JD. N-Tosyl-L-phenylalanyl-chloromethylketone reduces hypoxic-ischemic brain injury in rat pups. Eur J Pharmacol 2000; 390: 249-256
141. Man BH, Xu D, Choi J, et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 2002; 277: 30128-30136
142. Feng Y, Fratkin JD, LeBlanc MH. Inhibiting caspase-9 after injury reduces hypoxic ischemic neuronal injury in the cortex in the newborn rat. Neurosci Lett 2003; 344: 201-204
143. Ducrocq S, Benjelloun N, Plotkine M, et al. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem 2000; 74: 2504-2511
144. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50: 553-562
145. Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002; 22: 106-132
146. Volpe JJ. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003; 112: 176-180
147. Kinney HC, Back SA. Human oligodendroglial development: Relationship to periventricular leukomalacia. Semin Pediatr Neurol 1998; 5: 180-189
148. Back SA, Han BH, Luo NL, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002; 22: 455-463
149. Deng W, Poretz RD. Oligodendroglia in developmental neurotoxicity. Neurotoxicology 2003; 24: 161-178
150. Craig A, Ling LN, Beardsley DJ, et al. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 2003; 181: 231-240
151. Back SA, Luo NL, Borenstein NS, et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001; 21: 1302-1312
152. Liu Y, Silverstein FS, Skoff R, et al. Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatr Res 2002; 51: 25-33
153. Levison SW, Rothstein RP, Romanko MJ, et al. Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells. Dev Neurosci 2001; 23: 234-247
154. Ness JK, Romanko MJ, Rothstein RP, et al. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 2001; 23: 203-208
155. Skoff RP, Bessert DA, Barks JD, et al. Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice. Int J Dev Neurosci 2001; 19: 197-208
156. Haynes RL, Folkerth RD, Keefe RJ, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 2003; 62: 441-450
157. Tahraoui SL, Marret S, Bodenant C, et al. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 2001; 11: 56-71
158. Ivacko JA, Sun R, Silverstein FS. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr Res 1996; 39: 39-47
159. Cai Z, Pang Y, Xiao F, et al. Chronic ischemia preferentially causes white matter injury in the neonatal rat brain. Brain Res 2001; 898: 126-135
160. Mallard C, Welin AK, Peebles D, et al. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 2003; 28: 215-223
161. Ikeda T, Choi BH, Yee S, et al. Oxidative stress, brain white matter damage and intrauterine asphyxia in fetal lambs. Int J Dev Neurosci 1999; 17: 1-14
162. Toti P, De Felice C, Schurfeld K, et al. Cyclooxygenase-2 immunoreactivity in the ischemic neonatal human brain. An autopsy study. J Submicrosc Cytol Pathol 2001; 33: 245-249
163. Castiuo-Melendez M, Chow JA, Walker DW. Lipid peroxidation, caspase-3 immunoreactivity, and pyknosis in late-gestation fetal sheep brain after umbilical cord occlusion. Pediatr Res 2004; 55: 864-871
164. Laptook AR, Corbett RJ. The effects of temperature on hypoxic-ischemic brain injury. Clin Perinatol 2002; 29: 623-49, vi
165. Laptook AR, Corbett RJ, Sterett R, et al. Modest hypothermia provides partial neuroprotection for ischemic neonatal brain. Pediatr Res 1994; 35: 436-442
166. Towtighi J, Housman C, Heitjan DF, et al. The effect of focal cerebral cooling on perinatal hypoxic-ischemic brain damage. ACM Neuropathol (Berl) 1994; 87: 598-604
167. Williams GD, Dardzinski BJ, Buckalew AR, et al. Modest hypothermia preserves cerebral energy metabolism during hypoxia- ischemia and correlates with brain damage: A 31P nuclear magnetic resonance study in unanesthetized neonatal rats. Pediatr Res 1997; 42: 700-708
168. Young RS, Olenginski TP, Yagel SK, et al. The effect of graded hypothermia on hypoxic-ischemic brain damage: A neuropathologic study in the neonatal rat. Stroke 1983; 14: 929-934
169. Young RS, Kolonich J, Woods CL, et al. Behavioral performance of rats following neonatal hypoxia-ischemia. Stroke 1986; 17: 1313-1316
170. Bona E, Hagberg H, Loberg EM, et al. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: Short- and long-term outcome. Pediatr Res 1998; 43: 738-745
171. Gunn AJ, Gunn TR, de Haan HH, et al. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 1997; 99: 248-256
172. Tomimatsu T, Fukuda H, Endoh M, et al. Long-term neuroprotective effects of hypothermia on neonatal hypoxic-ischemic brain injury in rats, assessed by auditory brainstem response. Pediatr Res 2003; 53: 57-61
173. Tooley JR, Satas S, Porter H, et al. Head cooling with mild systemic hypothermia in anesthetized piglets is neuroprotective. Ann Neurol 2003; 53: 65-72
174. Wagner BP, Nedelcu J, Martin E. Delayed postischemic hypothermia improves long-term behavioral outcome after cerebral hypoxia-ischemia in neonatal rats. Pediatr Res 2002; 51: 354-360
175. Edwards AD, Yue X, Squier MV, et al. Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia. Biochem Biophys Res Commun 1995; 217: 1193-1199
176. Zhu CL, Wang XY, Cheng XY, et al. [Neuroprotective effect and mechanisms of hypothermia in neonatal rat cerebral hypoxic-ischemic damages]. Zhonghua Er Ke Za Zhi 2003; 41: 911-915
177. Tomimatsu T, Fukuda H, Endo M et al. Effects of hypothermia on neonatal hypoxic-ischemic brain injury in the rat: Phosphorylation of Akt, activation of caspase-3-like protease. Neurosci Lett 2001; 312: 21-24
178. Hashimoto T, Yonetani M, Nakamura H. Selective brain hypothermia protects against hypoxic-ischemic injury in newborn rats by reducing hydroxyl radical production. Kobe J Med Sci 2003; 49: 83-91
179. Brooks KJ, Hargreaves I, Bhakoo K, et al. Delayed hypothermia prevents decreases in N-acetylaspartate and reduced glutathione in the cerebral cortex of the neonatal pig following transient hypoxia-ischaemia. Neurochem Res 2002; 27: 1599-1604
180. Taylor DL, Mehmet H, Cady EB, et al. Improved neuroprotection with hypothermia delayed by 6 hours following cerebral hypoxia-ischemia in the 14-day-old rat. Pediatr Res 2002; 51: 13-19
181. Laptook AR, Corbett RJ, Sterett R, et al. Quantitative relationship between brain temperature and energy utilization rate measured in vivo using 31P and 1H magnetic resonance spectroscopy. Pediatr Res 1995; 38: 919-925
182. Trescher WH, Ishiwa S, Johnston MV. Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev 1997; 19: 326-338
183. Nedelcu J, Klein MA, Aguzzi A, et al. Resuscitative hypothermia protects the neonatal rat brain from hypoxic-ischemic injury. Brain Pathol 2000; 10: 61-71
184. Westin B, Miller JA Jr, Nyber R, et al. Neonatal asphyxia pallida treated with hypothermia alone or with hypothermia and transfusion of oxygenated blood. Surgery 1959; 45: 868-879
185. Battin MR, Dezoete JA, Gunn TR, et al. Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia. Pediatrics 2001; 107: 480-484
186. Battin MR, Penrice J, Gunn TR, et al. Treatment of term infants with head cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) after perinatal asphyxia. Pediatrics 2003; 111: 244-251
187. Debillon T, Daoud P, Durand P, et al. Whole-body cooling after perinatal asphyxia: A pilot study in term neonates. Dev Med Child Neurol 2003; 45: 17-23
188. Thoresen M. Cooling the newborn after asphyxia-physiological and experimental background and its clinical use. Semin Neonatol 2000; 5: 61-73
189. Whitelaw A, Thoresen M. Clinical trials of treatments after perinatal asphyxia. Curr Opin Pediatr 2002; 14: 664-668
190. Nighoghossian N, Trouillas P. Hyperbaric oxygen in the treatment of acute ischemic stroke: An unsettled issue. J Neurol Sci 1997; 150: 27-31
191. Veltkamp R, Warner DS, Domoki F, et al. Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res 2000; 853: 68-73
192. Mink RB, Dutka AJ. Hyperbaric oxygen after global cerebral ischemia in rabbits reduces brain vascular permeability and blood flow. Stroke 1995; 26: 2307-2312
193. Sunami K, Takeda Y, Hashimoto M, et al. Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Crit Care Med 2000; 28: 2831-2836
194. Atochin DN, Fisher D, Demchenko IT, et al. Neutrophil sequestration and the effect of hyperbaric oxygen in a rat model of temporary middle cerebral artery occlusion. Undersea Hyperb Med 2000; 27: 185-190
195. Atochin DN, Fisher D, Thorn SR, et al. [Hyperbaric oxygen inhibits neutrophil infiltration and reduces postischemic brain injury in rats]. Ross Fiziol Zh Im I M Sechenova 2001; 87: 1118-1125
196. Buras J. Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin 2000; 38: 91-109
197. Buras JA, Stahl GL, Svoboda KK, et al. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: The role of NOS. Am J Physiol Cell Physiol 2000; 278: C292-C302
198. Shiokawa O, Fujishima M, Yanai T, et al. Hyperbaric oxygen therapy in experimentally induced acute cerebral ischemia. Undersea Biomed Res 1986; 13: 337-344
199. Badr AE, Yin W, Mychaskiw G, et al. Effect of hyperbaric oxygen on striatal metabolites: A microdialysis study in awake freely moving rats after MCA occlusion. Brain Res 2001; 916: 85-90
200. Yin W, Badr AE, Mychaskiw G, et al. Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res 2002; 926: 165-171
201. del Zoppo G, Ginis I, Hallenbeck JM, et al. Inflammation and stroke: Putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000; 10: 95-112
202. del Zoppo GJ, Hallenbeck JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 2000; 98: 73-81
203. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 1999; 22: 391-397
204. Singhal AB, Wang X, Sumii T, et al. Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2002; 22: 861-868
205. Singhal AB, Dijkhuizen RM, Rosen BR, et al. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 2002; 58: 945-952
206. Hutchinson JH, Ker M, Williams K, et al. Hyperbaric oxygen in the resuscitation of the newborn. Lancet 1963; 2: 849-852
207. Chuba PJ, Aronin P, Bhambhani K, et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 1997; 80: 2005-2012
208. Rosasco SA, Calori B, Cabrini M, et al. [Hyperbaric chamber and surgery in newborn infants and infants]. Ann Chir Infant 1972; 13: 23-27
209. Ashamalla HL, Thom SR, Goldwein JW. Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children. The University of Pennsylvania experience. Cancer 1996; 77: 2407-2412
210. Collet JP, Vanasse M, Marois P, et al. Hyperbaric oxygen for children with cerebral palsy: A randomised multicentre trial. HBO-CP Research Group. Lancet 2001; 357: 582-586
211. Cronje F. Hyperbaric oxygen therapy for children with cerebral palsy. S Afr Med J 2001; 91: 615-616
212. Nuthall G, Seear M, Lepawsky M, et al. Hyperbaric oxygen therapy for cerebral palsy: Two complications of treatment. Pediatrics 2000; 106: E80
213. Rudge FW. Carbon monoxide poisoning in infants: Treatment with hyperbaric oxygen. South Med J 1993; 86: 334-337
214. Jain KK. Textbook of Hyperbaric Medicine. Seattle, WA: Hogrefe & Huber Publishers, 1999
215. Shankaran S. The postnatal management of the asphyxiated term infant. Clin Perinatol 2002; 29: 675-692
216. Ferriero DM. Timing is everything-delaying therapy for delayed cell death. Dev Neurosci 2002; 24: 349-351
217. Johnston, MV. Neurotransmitters and vulnerability of the developing brain. Brain Dev 1995; 17: 301-306